Susquehanna International Group
STAB

Susquehanna International Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Susquehanna International Group’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,228
Closed -$2K – 14324
2022
Q3 		$2K Sell
16,228
-135,620
-89% -$28.6K ﹤0.01% 12969
2022
Q2 		$43K Buy
+151,848
New +$39.3K ﹤0.01% 12064
2021
Q4 		– Sell
-12,619
Closed -$29K – 14270
2021
Q3 		$29K Sell
12,619
-11,376
-47% -$43.1K ﹤0.01% 12492
2021
Q2 		$131K Buy
+23,995
New +$129K ﹤0.01% 11933
2020
Q1 		– Sell
-13,922
Closed -$8K – 11125
2019
Q4 		$8K Sell
13,922
-7,121
-34% -$5.26K ﹤0.01% 9563
2019
Q3 		$21K Buy
+21,043
New +$28.4K ﹤0.01% 9943
2019
Q1 		– Sell
-15,268
Closed -$15K – 10148
2018
Q4 		$15K Sell
15,268
-12,042
-44% -$20.8K ﹤0.01% 8716
2018
Q3 		$55K Buy
27,310
+1,328
+5% +$2.85K ﹤0.01% 8818
2018
Q2 		$64K Buy
25,982
+13,995
+117% +$38.9K ﹤0.01% 9204
2018
Q1 		$36K Buy
+11,987
New +$42.3K ﹤0.01% 9045
2017
Q1 		– Sell
-22,216
Closed -$32K – 10279
2016
Q4 		$32K Buy
+22,216
New +$35.1K ﹤0.01% 9369
2014
Q2 		– Sell
-885
Closed -$12K – 10214
2014
Q1 		$12K Buy
+885
New +$14.4K ﹤0.01% 8805
2013
Q3 		– Sell
-545
Closed -$18K – 8886
2013
Q2 		$17K Buy
+545
New +$18.8K ﹤0.01% 8089

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's STAB Position: Q4 2022 in Review

Susquehanna International Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2022, closing a stake of 16,228 shares — an estimated $2K sold.

Susquehanna International Group first reported a position in STAB in Q2 2013 and held it in 13 quarters. The position peaked at $131K in Q2 2021. 29 funds tracked by Wall St. Rank hold STAB as of Q4 2022.

  • Susquehanna International Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 16,228 Statera Biopharma, Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • Susquehanna International Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • Susquehanna International Group's Statera Biopharma, Inc. Common Stock position peaked at $131K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.